^
BIOMARKER:

MET amplification + MET Exon 14 mutation

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Entrez ID:
MET amplification + MET Exon 14 mutation
NSCLC
crizotinib
Sensitive: C2 – Inclusion Criteria
MET amplification + MET Exon 14 mutation
LUAD
savolitinib
Sensitive: C4 – Case Studies